Related Experiment Video
Updated: Jan 9, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Behçet Disease and Cognitive Impairment: A Case Study of an Overlooked Symptom
Caroline Evanthe Nathania1, Astuti Prodjohardjono2,3, Noor Alia Susianti2
1Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Abstract:
BACKGROUND Behçet disease (BD) is a rare systemic vasculitis with diverse clinical manifestations, most commonly oral ulcers. Neurological involvement occurs in 5% to 15% of cases, often presenting as brainstem and myelopathic syndromes. However, cognitive impairment can develop even in the absence of overt neurological signs. A case-control study using the Brief Repeatable Battery of Neuropsychological Tests reported cognitive dysfunction in 38% of BD patients lacking overt neurological symptoms, suggesting that the cognitive dysfunction was immune-mediated. This case report points to the importance of heightened clinical vigilance in patients with BD presenting with subtle cognitive changes, even in the absence of neurological involvement. Routine neuropsychological screening could enable earlier detection and timely intervention, thereby reducing the risk of irreversible cognitive decline. CASE REPORT A 59-year-old woman with BD presented with progressive cognitive impairment 1 year after diagnosis. She had no prior cognitive problems or focal neurological signs. Her comorbid thymoma and hyperthyroidism remained clinically stable. Cognitive screening (MoCA-INA 27/30) revealed deficits in memory and attention, supported by suboptimal performance on the Digit Span and Trail-Making tests. Brain magnetic resonance imaging (MRI) ruled out stroke or neurodegeneration but demonstrated bilateral parietal atrophy and mild white-matter hyperintensities in the temporal and occipital lobes. She received donepezil, folic acid, cognitive stimulation, and immunosuppressive therapy. At 1-year follow-up, the Montreal Cognitive Assessment (MoCA-INA) score had normalized (30/30), with improved neurocognitive performance and stable daily functioning. CONCLUSIONS This case shows that cognitive impairment can present as an isolated manifestation of BD, even in the absence of overt neurological symptoms. Early neuropsychological screening and timely intervention can prevent progression and preserve quality of life.
Related Concept Videos
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Language and Cognition
Alzheimer's Disease: Treatment
Prosopagnosia

